Lucid Diagnostics Inc. (NASDAQ: LUCD) Stock Information | RedChip

Lucid Diagnostics Inc. (NASDAQ: LUCD) Listen to this Section


$0.82
-0.0145 ( -1.74% ) 69.6K

Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.

Market Data


Open


$0.82

Previous close


$0.84

Volume


69.6K

Market cap


$41.20M

Day range


$0.82 - $0.89

52 week range


$0.63 - $1.72

Insider Ownership Transactions

Total Amount Purchased: -2,591,500.00 | $ -2,126,325.75

Date Type Amount Purchased Purchaser
2024-05-09 Sale -241500.00 Matheis Dennis
2024-05-08 Sale -400000.00 O'Neil Shaun
2024-05-08 Sale -400000.00 Aklog Lishan
2024-05-08 Sale -400000.00 MCGRATH DENNIS M
2024-05-08 Sale -400000.00 Gordon Michael Adam
2024-02-23 Sale -150000.00 SOKOLOV JACQUE J
2024-02-23 Sale -150000.00 Lapidus Stanley
2024-02-23 Sale -150000.00 Sparks Ronald M
2024-02-23 Sale -150000.00 White Debra
2024-02-23 Sale -150000.00 Cox James L

SEC Fillings


Form Type Description Pages Date
8-k 8K-related 14 Aug 12, 2024
10-q Quarterly Reports 80 Aug 12, 2024
8-k 8K-related 15 Jul 24, 2024
8-k 8K-related 13 Jun 21, 2024
def Proxies and info statements 3 Jun 06, 2024
8-k 8K-related 13 May 24, 2024
pre Proxies and info statements 3 May 24, 2024
8-k 8K-related 14 May 14, 2024
10-q Quarterly Reports 77 May 13, 2024
4 Insider transactions 1 May 09, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.